Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Perspectives of employees with intellectual disabilities on themes relevant to their job satisfaction. an explorative study using photovoice.

Akkerman A, Janssen CG, Kef S, Meininger HP.

J Appl Res Intellect Disabil. 2014 Nov;27(6):542-54. doi: 10.1111/jar.12092. Epub 2014 Jan 27.

PMID:
24464972
2.

Course of health-related quality of life in 9-16-year-old children with cerebral palsy: associations with gross motor abilities and mental health.

Janssen CG, Voorman JM, Becher JG, Dallmeijer AJ, Schuengel C.

Disabil Rehabil. 2010;32(4):344-51. doi: 10.3109/09638280903166345.

PMID:
20055573
3.

Supporting affect regulation in children with multiple disabilities during psychotherapy: a multiple case design study of therapeutic attachment.

Schuengel C, Sterkenburg PS, Jeczynski P, Janssen CG, Jongbloed G.

J Consult Clin Psychol. 2009 Apr;77(2):291-301. doi: 10.1037/a0014274.

PMID:
19309188
4.

Metabolism and excretion of RWJ-333369 [1,2-ethanediol, 1-(2-chlorophenyl)-, 2-carbamate, (S)-] in mice, rats, rabbits, and dogs.

Mamidi RN, Mannens G, Annaert P, Hendrickx J, Goris I, Bockx M, Janssen CG, Kao M, Kelley MF, Meuldermans W.

Drug Metab Dispos. 2007 Apr;35(4):566-75. Epub 2007 Jan 12.

PMID:
17220243
5.

The absorption, metabolism, and excretion of the novel neuromodulator RWJ-333369 (1,2-ethanediol, [1-2-chlorophenyl]-, 2-carbamate, [S]-) in humans.

Mannens GS, Hendrickx J, Janssen CG, Chien S, Van Hoof B, Verhaeghe T, Kao M, Kelley MF, Goris I, Bockx M, Verreet B, Bialer M, Meuldermans W.

Drug Metab Dispos. 2007 Apr;35(4):554-65. Epub 2006 Aug 25.

PMID:
16936066
6.

Visual impairments in people with severe and profound multiple disabilities: an inventory of visual functioning.

van den Broek EG, Janssen CG, van Ramshorst T, Deen L.

J Intellect Disabil Res. 2006 Jun;50(Pt 6):470-5.

PMID:
16672040
7.
8.
9.

Synthesis and biodistribution of [(11)C]R116301, a promising PET ligand for central NK(1) receptors.

Van der Mey M, Janssen CG, Janssens FE, Jurzak M, Langlois X, Sommen FM, Verreet B, Windhorst AD, Leysen JE, Herscheid JD.

Bioorg Med Chem. 2005 Mar 1;13(5):1579-86.

PMID:
15698775
10.

Understanding challenging behaviour in people with severe and profound intellectual disability: a stress-attachment model.

Janssen CG, Schuengel C, Stolk J.

J Intellect Disabil Res. 2002 Sep;46(Pt 6):445-53. Review.

PMID:
12354315
11.

The quality of life of people with mental retardation: in search of an adequate approach.

Vreeke GJ, Janssen CG, Resnick S, Stolk J.

Int J Rehabil Res. 1997 Sep;20(3):289-301. Review.

PMID:
9331578
12.

Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of alpha-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase.

Pauwels R, Andries K, Debyser Z, Van Daele P, Schols D, Stoffels P, De Vreese K, Woestenborghs R, Vandamme AM, Janssen CG, et al.

Proc Natl Acad Sci U S A. 1993 Mar 1;90(5):1711-5.

13.

In vitro labeling of serotonin-S2 receptors: synthesis and binding characteristics of [3H]-7-aminoketanserin.

Wouters W, Janssen CG, Van Dun J, Thijssen JB, Laduron PM.

J Med Chem. 1986 Sep;29(9):1663-8.

PMID:
3746815

Supplemental Content

Loading ...
Support Center